IP Library › Granted Patent US 10,584,182
Granted Patent B2
US 10,584,182 · App. 15/067,726 · Granted Mar 10, 2020

Method and carrier complexes for delivering molecules to cells

Inventors: Hazel H. Szeto (New York, NY); Kesheng Zhao (Jackson Heights, NY); Hugh Robertson (New York, NY); Alex V. Birk (Woodhaven, NY)
Assignee: Cornell Research Foundation, Inc.
C07K17/00A61K31/713A61K38/47A61K47/64A61K47/645C07K5/08C07K5/1016C07K5/1019C12N9/2471C12N9/96C12N15/113C12N15/87C12Y302/01023C12N2310/3513C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,584,182
App. No.
15/067,726
Granted
Mar 10, 2020
Kind
B2
Abstract

The invention relates to carrier complexes and methods for delivering molecules to cells. The carrier complexes comprises a molecule and an aromatic cationic peptide in accordance with the invention. In one embodiment, the method for delivering a molecule to a cell comprises contacting the cell with a carrier complex. In another embodiment, the method for delivering a molecule to a cell comprises contacting the cell with a molecule and an aromatic cationic peptide.

Claims (20)

1. A carrier complex comprising a molecule conjugated to an aromatic cationic peptide, wherein the aromatic cationic peptide is selected from the group consisting of:

Phe-D-Arg-Phe-Lys-NH 2 (Phe 1 -DALDA),

D-Arg-2′,6′Dmt-Lys-Phe-NH 2 , and

2′,6′-Dmp-D-Arg-Phe-Lys-NH 2 (Dmp 1 -DALDA),

and wherein the molecule is a lipid, an enzyme, an antibody, or a neurotrophic growth factor.

2. The carrier complex according to claim 1 , wherein the molecule is conjugated to the aromatic cationic peptide by a linker.

3. The carrier complex according to claim 2 , wherein the linker is a component of the aromatic-cationic peptide.

4. The carrier complex according to claim 2 , wherein the linker is a component of the molecule.

5. The carrier complex according to claim 1 , wherein the molecule and aromatic cationic peptide are chemically bonded.

6. The carrier complex according to claim 1 , wherein the molecule and aromatic cationic peptide are physically bonded.

7. A method for delivering a molecule to a cell, the method comprising contacting the cell with a carrier complex, wherein the carrier complex comprises the molecule conjugated to an aromatic cationic peptide, wherein the aromatic cationic peptide is selected from the group consisting of:

Phe-D-Arg-Phe-Lys-NH 2 (Phe 1 -DALDA),

D-Arg-2′,6′-Dmt-Lys-Phe-NH 2 , and

2′,6′-Dmp-D-Arg-Phe-Lys-NH 2 (Dmp 1 -DALDA);

and wherein the molecule is a lipid, an enzyme, an antibody, or a neurotrophic growth factor.

8. The method according to claim 7 , wherein the molecule is conjugated to the aromatic cationic peptide by a linker.

9. The method according to claim 8 , wherein the linker is a component of the aromatic-cationic peptide.

10. The method according to claim 8 , wherein the linker is a component of the molecule.

11. The method according to claim 7 , wherein the molecule and aromatic cationic peptide are chemically bonded.

12. The method according to claim 7 , wherein the molecule and aromatic cationic peptide are physically bonded.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2017
From: SZETO, HAZEL H.; ZHAO, KESHENG; ROBERTSON, HUGH D.; BIRK, ALEX V.
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 041277/0815 →
Continuity (5)
Continuation 13422722 · Mar 16, 2012
Continuation 12631048 · Dec 4, 2009
Continuation 10838135 · May 3, 2004
Provisional Application 60467516 · May 1, 2003
Related Publication 20170035899A1 · Feb 9, 2017